Relmada Therapeutics, Inc. · NASDAQ:RLMD
Venrock Healthcare Capital Partners III, L.P. reported a 6.20% stake in Relmada Therapeutics, Inc. (Schedule 13G)
Event Jun 2, 2026 · Filed Jun 9, 2026
Venrock Healthcare Capital Partners III, L.P. reported a 6.20% stake in Relmada Therapeutics, Inc., 6,508,433 shares, as a passive investor on Jun 2, 2026. Filed Jun 9, 2026 (Schedule 13G).
- Stake
- 6.20%
- Shares
- 6,508,433
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 7 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Venrock Healthcare Capital Partners III, L.P. | 6.20% | 6,508,433 |
| VHCP Co-Investment Holdings III, LLC | 6.20% | 6,508,433 |
| Venrock Healthcare Capital Partners EG, L.P. | 6.20% | 6,508,433 |
| VHCP Management III, LLC | 6.20% | 6,508,433 |
| VHCP Management EG, LLC | 6.20% | 6,508,433 |
| Nimish Shah | 6.20% | 6,508,433 |
| Bong Y. Koh | 6.20% | 6,508,433 |
Source
Related
- Relmada Therapeutics, Inc.
- Venrock Healthcare Capital Partners III, L.P.
- Relmada Therapeutics, Inc. shareholders
- Form 4 · Shenouda Maged · Sep 11, 2026
- Form 4 · Traversa Sergio · Sep 11, 2026
- Schedule 13G/A · Squadron Capital Management LLC · Aug 14, 2026
- Schedule 13G · BlackRock, Inc. · Jul 29, 2026
- Schedule 13G · Millennium Management LLC · Jun 22, 2026